Prostate cancer news reports: Sunday, May 24, 2009

Today’s news reports deal with such matters as:

  • Advances in radical prostatectomy
  • Variations in mutation in androgen-resistant patients
  • Data from a Phase I/II trial of AT-101
  • The link between CTC level and response to therapy with abiraterone … READ MORE …

The Monday news update: March 2, 2009

New reports today address:

  • Positive surgical margins: RALP vs. RRP
  • Circulating tumor cells levels and survival of castration-resistant prostate cancer patients
  • Patient preference and management of post-surgical incontinence … READ MORE …

Tuesday’s news reports: February 16, 2009

For the engineers, the scientists, and other technically minded readers, there are a number of very “dense” scientific news reports today. … READ MORE …

Can CTC counts be used as surrogate endpoints in clinical trials?

Intermediate or surrogate endpoints for survival can shorten timelines for drug approval. A paper just published on line in Lancet Oncology aimed to assess the value of circulating tumor cell (CTC) counts as a prognostic factor for survival. … READ MORE …

Thursday’s other news reports: February 5, 2009

There are a number of additional reports in today’s news (above and beyond the reports on risks associated with disseminated tumor cells and a new review of PSA and PCA3 testing as aids to diagnosis): … READ MORE …

The prostate cancer news update: Friday, October 10

Today’s news includes information about:

  • A review of the risk associated with testosterone therapy in men with low testosterone levels
  • Issues related to stress and coping among couples dealing with prostate cancer
  • The pivotal trial leading to approval of circulating T-cell counts as a means to evaluate treatment of men with very late-stage prostate cancer … READ MORE …

Prostate cancer news update: Tuesday, August 26

There are several interesting news items today, as follows:

  • Ethnic variation in the performance of PSA and PSA density as markers for risk of prostate cancer
  • Potential underuse of active surveillance in eligible patients
  • Application of active surveillance in a 40-patient case series
  • The potential to eliminate the need for a urethral (Foley) catheter post-surgery
  • Circulating tumor cell levels as a predictor for response to androgen deprivation therapy … READ MORE …